Paxlovid Reduces Short and Long-Term Adverse Outcomes in COVID-19 Patients with Kidney Disease
Published: January 6th 2025 | Updated: January 6th 2025Recent study highlights Paxlovid’s ability to reduce hospitalizations and mortality in high-risk populations, but underscores the need for personalized treatment.